The Academy of Medical Sciences and the Royal Society have announced their new Fellows list for 2020. Congratulations to the following BSI members on being elected in recognition of their outstanding contributions to the discipline.
Academy of Medical Sciences
Menna Clatworthy, NIHR Research Professor and Professor of Translational Immunology, University of Cambridge and Associate Faculty, Wellcome Sanger Institute. Menna's research is focused on understanding the regulation of antibody generation and effector function, novel methods of targeting humoral immunity in kidney transplantation, and the role of tissue-environment in shaping resident immune cell activation and function particularly in the kidney. She set up her own lab in 2013 and was awarded an NIHR Research Professorship in 2018. She is also an active participant in the Human Cell Atlas Project utilizing single-cell technologies to better understand the cellular landscape of the human kidney. She was awarded the British Renal Association Raine Award and the Academy of Medical Sciences/Medical Research Society Young Investigator Award for her PhD investigating the role of IgG antibodies in autoimmunity and infection. She subsequently completed a Wellcome Trust Intermediate Fellowship at Cambridge and the National Institutes of Health, Bethesda, USA.
Stuart Elborn, Pro-Vice Chancellor for Medicine, Health and Life Sciences, Queen's University Belfast. Stuart's is an internationally renowned specialist who main research concerns cystic fibrosis, specifically understanding pathophysiology of infection and inflammation as well as the translation of new therapies into clinical practice. His work has led to major clinical breakthroughs in the treatment of people with cystic fibrosis, and in 2013, he received a CBE for services to healthcare in Northern Ireland. Professor Elborn was one of the longest-serving presidents of the European Cystic Fibrosis Society, holding the role between 2007 and 2015. He has also spent time as a trustee and chair of the research and medical advisory committees of the Cystic Fibrosis Trust (2002 to 2014) and currently sits on the scientific advisory board. He also leads research programmes in chronic obstructive pulmonary disorder and bronchiectasis.
Gerard Graham, Gardiner Chair of Immunology, University of Glasgow. Gerard has a long-standing research interest in chemokines and their receptors and has been working in this field for two decades and has published widely in this important area. He also served on the Medical Research Council's Infections and Immunity Board for four years and is currently Chair of the Wellcome Trust Expert Review Group on the Immune System in Health and Disease. Professor Graham is a Fellow of the Royal Society of Edinburgh and holds a Wolfson-Royal Society Research merit award.
Sophie Hambleton, Professor of Paediatrics and Immunology, Newcastle University. Sophie trained in clinical paediatrics and immunology, and her research explores what children with inborn errors of immunity can teach us about the normal immune system, and how that knowledge can inform clinical practice. Since 2008, Sophie has been a consultant on the immunology and infectious diseases team at the Great North Children's Hospital (GNCH) and leads a research team at Newcastle University working to discover the genetic causes of immunodeficiency in patients. Sophie is also a member of the UKPIN Genomics Steering Group and the MRC Infection and Immunity Board.
Muzlifah Haniffa, Wellcome Trust Senior Research Fellow in Clinical Science, Newcastle University, Associate Faculty, Wellcome Sanger Institute. Muzlifah is a dermatologist and immunologist pioneering applications of single-cell genomics technologies to understand tissue homeostasis, immunity and disease pathogenesis. A significant goal of her lab research is decoding the development and functional maturation of the human immune system. Muzlifah has received numerous awards and fellowships for work, and also leads a Wellcome Trust funded public engagement programme called Inside Skin, an interdisciplinary dialogue between science and art relating to skin and the immune system in collaboration with the Newcastle Centre for the Literary Arts and Culture Lab.
Emma Morris, Professor of Clinical Cell & Gene Therapy and Honorary Consultant, University College London, University College London Hospital and Royal Free London Hospital. Emma's research group explores the specificity and the function of gene-modified immune cells which can then be used to treat cancer, infection, or immune system disorders. Her clinical interest is in the field of haematopoietic stem cell transplantation. Emma is currently secretary of the Clinical trials Committee of the British Society for Blood and Marrow Transplantation, a member of the NCRI Low Grade Lymphoma Subgroup and sits on the Editorial Board of the British Journal for Haematology.
Hugh Willison, Professor of Neurology, University of Glasgow. Huge leads the Neuroimmunology Research Group within the Glasgow Biomedical Research Centre. He has a specialist interest in peripheral nerve disorders and researches this area at the clinical and laboratory level. In particular, he combines his clinical and research activity on autoimmune diseases including Guillain Barre syndrome and chronic inflammatory neuropathies. He also directs a clinical diagnostic laboratory that conducts immunological tests of relevance to peripheral nerve disorders, including anti-glycolipid, anti-MAG and anti-neuronal antibodies. Hugh also holds an Honorary Clinical Consultant Neurologist contract with the South Glasgow University Hospitals NHS Trust.
Find more information about the 2020 Academy of Medical Sciences on their website.
Royal Society Fellows
Gordon Brown, Professor in Immunology, MRC Centre for Medical Mycology, University of Exeter. Gordon’s research focuses on understanding the role of C-type lectin receptors (CLRs) in immunity. He has provided important insights into how CLRs enable immune cells to sense pathogens (particularly fungi), how this information is transmitted intracellularly, and how these receptors initiate and control innate and adaptive immunity. He has also translated his discoveries into human benefit, leading to the identification of polymorphisms and other factors that are associated with disease susceptibility, as well as a novel therapy that was successfully tested in patients.
Find more information about the 2020 Royal Society Fellows on their website.